{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T02:02:01Z","timestamp":1780452121953,"version":"3.54.1"},"reference-count":28,"publisher":"American Society for Microbiology","issue":"5","license":[{"start":{"date-parts":[[2003,5,1]],"date-time":"2003-05-01T00:00:00Z","timestamp":1051747200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2003,5]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>\n            We performed a randomized controlled trial involving 55 adult patients with enteric fever to compare ciprofloxacin and chloramphenicol. Blood and bone marrow cultures and cytokine profiles during therapy were done to compare the clinical and bacteriological efficacies of these drugs. All patients were randomly assigned to receive chloramphenicol (500 mg four times a day orally) for 14 days or ciprofloxacin (500 mg twice a day orally) for 7 days. In each treatment group, patients were subsequently randomized to have blood and bone marrow cultured after either 3 or 5 days of treatment. Twenty-seven patients received chloramphenicol, and 28 received ciprofloxacin. The two groups were similar in terms of baseline characteristics. No significant differences in clinical cure and time to defervescence were found. All strains isolated were susceptible to both antibiotics. Although ciprofloxacin was more effective in the elimination of\n            <jats:italic>Salmonella<\/jats:italic>\n            <jats:italic>enterica<\/jats:italic>\n            serovars Typhi and Paratyphi A from bone marrow than chloramphenicol, there was still an impressive persistence of\n            <jats:italic>Salmonella<\/jats:italic>\n            in the bone marrow culture (67%). In the ciprofloxacin-treated patients the suppressed cytokine production capacity showed a trend to normalize earlier than in patients treated with chloramphenicol.\n          <\/jats:p>","DOI":"10.1128\/aac.47.5.1727-1731.2003","type":"journal-article","created":{"date-parts":[[2003,4,22]],"date-time":"2003-04-22T21:03:23Z","timestamp":1051045403000},"page":"1727-1731","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":35,"title":["Persistence of Salmonellae in Blood and Bone Marrow: Randomized Controlled Trial Comparing Ciprofloxacin and Chloramphenicol Treatments against Enteric Fever"],"prefix":"10.1128","volume":"47","author":[{"given":"M. Hussein","family":"Gasem","sequence":"first","affiliation":[{"name":"Department of Medicine, Dr. Kariadi Hospital, and Faculty of Medicine, Diponegoro University, Semarang, Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monique","family":"Keuter","sequence":"additional","affiliation":[{"name":"Department of General Internal Medicine, University Medical Center St. Radboud, Nijmegen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wil M. V.","family":"Dolmans","sequence":"additional","affiliation":[{"name":"Department of General Internal Medicine, University Medical Center St. Radboud, Nijmegen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna","family":"van der Ven-Jongekrijg","sequence":"additional","affiliation":[{"name":"Department of General Internal Medicine, University Medical Center St. Radboud, Nijmegen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Djokomoeljanto","sequence":"additional","affiliation":[{"name":"Department of Medicine, Dr. Kariadi Hospital, and Faculty of Medicine, Diponegoro University, Semarang, Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos W. M.","family":"van der Meer","sequence":"additional","affiliation":[{"name":"Department of General Internal Medicine, University Medical Center St. Radboud, Nijmegen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","first-page":"597","volume":"1","year":"1990","unstructured":"Bailly, S., M. Fay, Y. Roche, and M. A. Gougerot-Pocidalo. 1990. Effects of quinolones on tumor necrosis factor production by human monocytes. Int. J. Immunopharmacol.1:597-607.","journal-title":"Int. J. Immunopharmacol."},{"key":"e_1_3_2_3_2","unstructured":"Bergan T. 1985. Phamacokinetics of quinolones. Quinolones Bull. I :2-3"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.34.3.481"},{"key":"e_1_3_2_5_2","unstructured":"Chambers H. F. 2001. Protein synthesis inhibitors and miscellaneous antibacterial agents p. 1239-1272. In J. G. Hardman and L. E. Limbird (ed.) Goodman and Gilman\u2019s the pharmacological basis of therapeutics 10th ed. McGraw-Hill New York N.Y."},{"key":"e_1_3_2_6_2","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0163-4453(92)91519-H","volume":"25","year":"1992","unstructured":"Chew, S. K., E. H. A. Monteiro, Y. S. Lim, and D. M. Allen. 1992. A 7-day course of ciprofloxacin for enteric fever. J. Infect.25:267-271.","journal-title":"J. Infect."},{"key":"e_1_3_2_7_2","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1136\/jcp.38.4.442","volume":"38","year":"1985","unstructured":"Easmon, C. S., and J. P. Crane. 1985. Uptake of ciprofloxacin by macrophages. J. Clin. Pathol.38:442-444.","journal-title":"J. Clin. Pathol."},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/18.Supplement_C.43"},{"key":"e_1_3_2_9_2","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1002\/sim.4780111304","volume":"11","year":"1992","unstructured":"Frison, L., and S. J. Pocock. 1992. Repeated measures in clinical trials: analysis using mean summary statistics and its implications for design. Stat. Med.11:1685-1704.","journal-title":"Stat. Med."},{"key":"e_1_3_2_10_2","first-page":"164","volume":"47","year":"1995","unstructured":"Gasem, M. H., W. M. V. Dolmans, B. B. Isbandrio, H. Wahyono, M. Keuter, and R. Djokomoeljanto. 1995. Culture of Salmonellatyphi and Salmonella paratyphi from blood and bone marrow in suspected typhoid fever. Trop. Geogr. Med.47:164-167.","journal-title":"Trop. Geogr. Med."},{"key":"e_1_3_2_11_2","doi-asserted-by":"crossref","unstructured":"Gotuzzo E. and C. Carillo. 1992. Typhoid fever. Evaluation of the efficacy and safety of ciprofloxacin in comparison with chloramphenicol p. 16-22. In H. L. Dupont (ed.) Use of quinolones in travel medicine. Springer-Verlag Berlin Germany.","DOI":"10.1007\/978-3-642-77077-7_3"},{"key":"e_1_3_2_12_2","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1093\/jac\/33.5.1055","volume":"33","year":"1994","unstructured":"Isbandrio, B. B., M. H. Gasem, W. M. V. Dolmans, and J. A. A. Hoogkamp-Korstanje. 1994. Comparative activities of three quinolones and seven comparison standard drugs against Salmonellatyphi from Indonesia. J. Antimicrob. Chemother.33:1055-1056.","journal-title":"J. Antimicrob. Chemother."},{"key":"e_1_3_2_13_2","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1017\/S095026880005247X","volume":"116","year":"1996","unstructured":"Jesudason, M. V., R. John, and T. J. John. 1996. The concurrent prevalence of chloramphenicol-sensitive and multi-drug resistant Salmonella typhi in Vellore, S. India. Epidemiol. Infect.116:225-227.","journal-title":"Epidemiol. Infect."},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/169.6.1306"},{"key":"e_1_3_2_15_2","first-page":"3169","volume":"11","year":"2000","unstructured":"Khan, A. A., T. R. Slifer, F. G. Araujo, Y. Suzuki, and J. S. Remington. 2000. Protection against lipopolysaccharide-induced death by fluoroquinolones. Antimicrob. Agents Chemother.11:3169-3173.","journal-title":"Antimicrob. Agents Chemother."},{"key":"e_1_3_2_16_2","first-page":"105","volume":"7","year":"1989","unstructured":"Limson, B. M., and R. T. Littaua. 1989. Comparative study of ciprofloxacin versus cotrimoxazole in the treatment of Salmonella enteric fever. Infection7:105-106.","journal-title":"Infection"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.34.3.398"},{"key":"e_1_3_2_18_2","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/0035-9203(92)90264-D","volume":"86","year":"1992","unstructured":"Meskin, S., M. S. Jacob, R. Macaden, J. S. Keystone, P. E. Kozarsky, A. N. Ramachadran, and B. Metchock. 1992. Short-course treatment of typhoid fever with ciprofloxacin in South India. Trans. R. Soc. Trop. Med. Hyg.86:446-447.","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"e_1_3_2_19_2","unstructured":"National Committee for Clinical Laboratory Standards. 2000. Performance standards for antimicrobial susceptibility testing. Standard M100-S10. National Committee for Clinical Laboratory Standards Wayne Pa."},{"key":"e_1_3_2_20_2","doi-asserted-by":"crossref","unstructured":"Perea E. J. I. Garcia and A. Pascual. 1992. Comparative penetration of lomefloxacin and other quinolones into human phagocytes. Am. J. Med. 92: 48S-51S.","DOI":"10.1016\/0002-9343(92)90309-Y"},{"key":"e_1_3_2_21_2","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/00007611-199602000-00017","volume":"89","year":"1996","unstructured":"Rathore, M. H., D. Bux, and M. Hasan. 1996. Multidrug-resistant Salmonella typhi in Pakistani children: clinical features and treatment. South. Med. J.89:235-237.","journal-title":"South. Med. J."},{"key":"e_1_3_2_22_2","first-page":"99","volume":"2","year":"1987","unstructured":"Roche, Y., M. Fay, and M. A. Gougerot-Pocidalo. 1987. Effects of quinolones on interleukin-1 production in vitro by human monocytes. Immunopharmacology2:99-109.","journal-title":"Immunopharmacology"},{"key":"e_1_3_2_23_2","first-page":"1226","volume":"5472","year":"1965","unstructured":"Sanders, W. L. 1965. Treatment of typhoid fever: a comparative trial of ampicillin and chloramphenicol. Br. Med. J.5472:1226-1227.","journal-title":"Br. Med. J."},{"key":"e_1_3_2_24_2","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1007\/BF01966999","volume":"10","year":"1991","unstructured":"Shalit, I. 1991. Immunological aspect of new quinolones. Eur. J. Clin. Microbiol. Infect. Dis.10:262-266.","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"e_1_3_2_25_2","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1093\/jac\/30.5.707","volume":"30","year":"1992","unstructured":"Uwaydah, K., H. Al Soub, and I. Matar. 1992. Randomized prospective study comparing two regimens of ciprofloxacin for the treatment of typhoid fever. J. Antimicrob. Chemother.30:707-711.","journal-title":"J. Antimicrob. Chemother."},{"key":"e_1_3_2_26_2","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1046\/j.1365-3156.1999.43374.x","volume":"4","year":"1999","unstructured":"van den Bergh, E. T. A. M., M. H. Gasem, M. Keuter, and W. M. V. Dolmans. 1999. Outcome in three groups of patients with typhoid fever in Indonesia between 1948 and 1990. Trop. Med. Int. Health4:211-215.","journal-title":"Trop. Med. Int. Health"},{"key":"e_1_3_2_27_2","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1093\/jac\/44.2.193","volume":"44","year":"1999","unstructured":"van den Broek, P. J., T. G. Koot, E. van Strijen, and H. Mattie. 1999. Intracellular activity of trovafloxacin against Staphylococcus aureus. J. Antimicrob. Chemother.44:193-199.","journal-title":"J. Antimicrob. Chemother."},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V90.3.1101.1101_1101_1108"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01992163"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.47.5.1727-1731.2003","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.47.5.1727-1731.2003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T18:15:20Z","timestamp":1645467320000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.47.5.1727-1731.2003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,5]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2003,5]]}},"alternative-id":["10.1128\/AAC.47.5.1727-1731.2003"],"URL":"https:\/\/doi.org\/10.1128\/aac.47.5.1727-1731.2003","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,5]]},"assertion":[{"value":"2002-09-26","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2003-02-18","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2003-05-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}